Dennis Barnes

Managing Director at Mayne Pharma

Dennis Barnes is a Managing Director at Dovetail Consulting Group. He has nearly 25 years of experience serving life sciences companies both as an external resource evaluating and testing the effectiveness of compliance programs, and as an internal member of the senior management team charged with building and implementing compliance programs, leading risk management initiatives, and serving as an independent voice reporting directly to Boards of Directors.

Dennis served as the Vice President of Global Governance, Risk & Compliance at Mayne Pharma where he was responsible for building and implementing the US Healthcare Compliance Program, and developing and executing a global risk management program, among other responsibilities.

Before joining Mayne Pharma, Dennis served as Vice President, Global Compliance Officer for PAREXEL International Inc., the second largest clinical research organization (CRO) in the world, where he focused on partnering with key global pharmaceutical clients to support their compliance with important elements of their Corporate Integrity and Deferred Prosecution Agreements. Dennis managed three teams while at PAREXEL, including a US Spend Reporting Team, a US Third Party Due Diligence Team and a Global Third-Party Due Diligence Team located in Hyderabad, India.

Dennis earned a BA in Economics from Bucknell University, a JD from the University of Notre Dame School of Law, and an MBA from the University of Texas at Austin, McCombs Graduate School of Business. Dennis is also a Certified Public Accountant, licensed in the Commonwealth of Pennsylvania. In 2022, Dennis earned the Certified Information Privacy Professional (CIPP/US) designation and the Certified Information Privacy Manager (CIPM) designation from the International Association of Privacy Professionals (IAPP) and has begun helping his clients develop and implement elements of their privacy programs.